Acute Pyelonephritis in Adults
Authors:
- 4 January 2018
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 378 (1) , 48-59
Abstract
Decisions regarding disposition and treatment in patients with pyelonephritis should be guided by assessment of the likelihood of pathogen resistance to antimicrobial agents and by patient factors (e.g., illness severity, coexisting conditions, and psychosocial situation).Keywords
This publication has 45 references indexed in Scilit:
- Community Transmission in the United States of a CTX-M-15-Producing Sequence Type ST131 Escherichia coli Strain Resulting in DeathJournal of Clinical Microbiology, 2011
- Predicting the Need for Radiologic Imaging in Adults with Febrile Urinary Tract InfectionClinical Infectious Diseases, 2010
- Emphysematous pyelonephritisBJU International, 2010
- Pyelonephritis in PregnancyDrugs, 2010
- Population-Based Epidemiologic Analysis of Acute PyelonephritisClinical Infectious Diseases, 2007
- Antibiotic treatment for acute ‘uncomplicated’ or ‘primary’ pyelonephritis: a systematic, ‘semantic revision’International Journal of Antimicrobial Agents, 2006
- Acute Pyelonephritis Among AdultsPharmacoEconomics, 2005
- Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infectionsInternational Journal of Antimicrobial Agents, 2004
- Fewer Bacterial Relapses after Oral Treatment with Norfloxacin than with Ceftibuten in Acute Pyelonephritis Initially Treated with Intravenous CefuroximeScandinavian Journal of Infectious Diseases, 2001
- Quantitative definition of bacteriuriaThe American Journal of Medicine, 1983